Current treatment: options for continuing or switching
- Oral bisphosphonates
-
Continue or switch to intravenous bisphosphonates
- Intravenous bisphosphonates
- Continue
- Denosumab
- Continue
- Selective estrogen receptor modulator (SERM, eg, raloxifene)
-
Drug holiday for 35 days
- Strontium ranelate
-
Switch to intravenous bisphosphonate
- Teriparatide, PTH
-
Continue (up to a maximum of 24 months from initiation)
<%= buttons %>